APAC Cell & Gene Therapy Market 2020

Featuring 62 Cell & Gene Therapy companies from China, Taiwan, Korea, Japan, South Asia, SEA, and Australia!

About APAC Cell & Gene Therapy Market 2020

APAC Cell & Gene Therapy Market 2020 covers comprehensive information on parameters such as product pipeline, future expansion plans, technologies used, production capacity, temperature requirements, manufacturing capabilities, and SCM preferences. It also contains analysis on market growth, M&As, financial updates, upcoming facilities and more!

It provides readers a closer look into companies such as Chugai, Tessa Therapeutics, Daewong Pharm, Eutilex, Carmine Therapeutics, Sumitomo Dainippon, Unicocell Biomed, JW Creagene, Takara Bio and more!

Key Takeaways

Insights on production processes, equipment, logistics and SCM services various BioPharmas and CMOs currently and plan to employ.
Understand the facility expansion plans of key players in the APAC region.
Identify potential clients who would be interested in your latest technology or service.

Report Snapshot

Featured Companies

PURCHASE YOUR REPORT HERE!

For offline payments or inquiries, kindly contact:

Kashmiira Nayar

e: kashmiira.nayar@imapac.com

t: +65 31090122

Single-User Access

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Multi-User Access

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users.

Corporate Access

Upto 10 users: This license entitles the buyer of the report to share, distribute the report (either full or in part) with 10 other employees of the same firm /enterprise.

Table of Contents

Section 1
• Preface
• Report Scope & Data Coverage
• IMAPAC’s Research Methodology

Section 2 – Company-Wise Analysis
• Company Overview
• GMP Certifications
• Facilities’ Size, Equipment, Capabilities etc.
• Expansion Plans
• Current Product Pipeline
• Stage of Development
• Production Capacity
• Platform Technologies
• Product Temperature Requirements
• Preferred Delivery and SCM methods
• Partnerships & Collaborations
• Financial Performance
• Company Highlights, News & Updates
• Interviews

Section 3: Region-Wise Data & Analysis {Regions Covered: China, Taiwan, Japan& Korea, India, Australia & Sea}
• Distribution of Cell & Gene Therapy Companies
• Targeted Disease Types
• Stage of clinical trial phase
• Allogenic vs Autolog0us Therapies
• Targeted Antigens

Section 4: Our Other Reports
• Bibiliography
• Disclaimer
• About Us
• Our Other Reports